Patient subgroup analyses of the treatment effect of subcutaneous interferon β-1a on development of multiple sclerosis in the randomized controlled REFLEX study

Patient subgroup analyses of the treatment effect of subcutaneous interferon β-1a on development of multiple sclerosis in the randomized controlled REFLEX study

The REFLEX study (NCT00404352) established that subcutaneous (sc) interferon (IFN) β-1a reduced the risks of McDonald MS (2005 criteria) and clinically definite multiple sclerosis (CDMS) in patients with a first clinical demyelinating event suggestive of MS. The aim of this subgroup analysis was to...

Full description

Bibliographic Details
Main Authors: Freedman, Mark S., De Stefano, Nicola, Barkhof, Frederik, Polman, Chris H., Comi, Giancarlo, Uitdehaag, Bernard M. J., Casset-Semanaz, Florence, Hennessy, Brian, Lehr, Lorenz, Stubinski, Bettina, Jack, Dominic L., Kappos, Ludwig
Format: Online
Language:English
Published: Springer Berlin Heidelberg 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3948518/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3948518/

Similar Items